Читать книгу Neurology - Charles H. Clarke - Страница 83

Anti‐TNF, anti‐VEGF and anti‐IL‐6: some of these are targeted therapies, such as etanercept, widely used in rheumatoid. Others are antibodies with anticytokine activity such as bevacizumab which acts as an anti‐VEGF agent, or tocilizumab which is anti‐IL‐6.